Astrazeneca shares jump as it kicks off $2bn drug pipeline investment Business Astrazeneca’s share jumped in early trading on Friday, as investors cheered plans to bolster its drug pipeline. The pharmaceutical giant’s shares increased 3.1 per cent to £134.50 on Friday morning, as it launched a $2bn (£1.5bn) restructuring programme to boost investment in its drug channel. The FTSE 100 company said the three-year programme would shift [...]
GSK shares slump as vaccine sales fall Healthcare GSK shares have fallen the steepest since April, after the British pharmaceuticals giant reported a sharp drop in vaccine sales. The FTSE 100 medicines titan slumped up to five per cent in early trading on Wednesday, as investors looked past the group’s higher-than-expected revenue. The London-based group posted a £8.9bn turnover in the third quarter, [...]
Astrazeneca invests $2bn in cancer drug tie-up Markets Astrazeneca has invested $2bn in US pharmaceutical firm Summit Therapeutics as part of a blockbuster cancer research tie-up. The FTSE 100 drugs giant has agreed to buy 109,000 shares in Nasdaq-listed Summit for $18.36 per share as part of the deal. Shares in Astrazeneca jumped by 1.4 per cent to 12,664p in early trading. The tie-up [...]
Astrazeneca share price tumbles on $400bn megamerger talks August 3, 2026 Astrazeneca’s share price slumped sharply on Monday as investors baulked at a potential $400bn megamerger with US rival Bristol Myers Squibb. Shares in the UK drugmaker slid six per cent in early trading to 11,866p after the Financial Times reported it has been holding talks regarding a potential tie-up with the US group in recent [...]
Astrazeneca explores $400bn megadeal with US rival August 3, 2026 Astrazeneca is exploring a $400bn (£300bn) merger with US rival Bristol Myers Squibb, in a deal that would create one of the world’s largest pharmaceutical groups. The FTSE 100 giant has held talks with the US group in recent months about a possible tie-up, according to reports in the Financial Times. Talks could lead to a [...]
Sweeping job cuts at GSK to fund £400m Cambridge campus July 28, 2026 GSK is poised to slash its back office headcount to help fund a £400m mega-campus in Cambridge, in a move it hopes will bolster its drugs pipeline anFd stave off a looming patent cliff-edge. In his first major update as chief executive, Luke Miels unveiled plans to find £1.9bn of savings over the next three [...]
As it happened: Stocks rise; oil falls after Trump pauses Iran strikes July 27, 2026 Welcome back to the City AM FTSE 100 liveblog. It’s Monday and the FTSE 100 has made a positive start to the week, gaining more than 70 points on the market open after oil prices began to fall from last week’s two-month highs. Brent crude, the international benchmark for oil prices, slipped to $90.58 in early trading [...]
LSE draws up ‘worst case scenario’ US listing flight risk June 28, 2026 The London Stock Exchange is preparing for as many as 20 FTSE 100-listed companies to move their direct listings to New York, according to reports, in a move that would leave a £2bn gap in the Treasury’s earnings from stamp duty on share trades. The exchange has drawn up a worst-case scenario plan in which [...]
Astrazeneca ploughs £300m into UK in surprise U-turn April 29, 2026 British drugs giant Astrazeneca has promised to plough £300m into its UK operations, just months after cancelling a nine-figure investment in a new lab after getting in a spat with the UK government over drug pricing. In a stunning volte-face, the UK’s largest pharmaceutical company said it would revive its £200m investment into a megalab [...]
FTSE 100 Live: Stocks drop as oil holds firm over $110; UK growth slashed April 29, 2026 Good morning and welcome back to the City AM liveblog. Oil prices are holding firm tipping over the $110 mark, bringing the cost of a barrel closer to the highs of $118 it peaked at earlier in the Iran war. Brent crude – the international benchmark for oil – advanced another one per cent on [...]